{"url_path":"/sec/crsp/8-k/2026-06-04/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-257593-index.html","accession_number":"0001193125-26-257593","cik":"0001674416","ticker":"CRSP","issuer_name":"CRISPR Therapeutics AG","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-257593-index.html","primary_entity_key":"0001674416","primary_entity_name":"CRISPR Therapeutics AG"},"word_count":106,"has_tables":true,"body_markdown":"Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\n\nOn June 4, 2026, at the Annual Meeting, the shareholders of the Company approved amendments to the articles of association of the Company (the “Articles of Association”) as described in the Company’s Proxy Statement. The Company’s amended and restated Articles of Association become effective upon registration in the Commercial Register in the canton of Zug, Switzerland on or about June 5, 2026, subject to the approval by the Swiss Federal Commercial Authority. A copy of the amended and restated Articles of Association is attached hereto as Exhibit 3.1 and incorporated herein by reference."}